News | July 30, 2025
Vijaya Diagnostic reports Q1 FY26 consolidated PAT at Rs. 38.33 Cr
The company would be commissioning 3 hubs in Q2 FY26 across our Core Geography and West Bengal
The company would be commissioning 3 hubs in Q2 FY26 across our Core Geography and West Bengal
Torrent Pharmaceuticals has reported total income of Rs. 3,141 crores during the period ended June 30, 2025
Piramal Pharma has reported total income of Rs. 1,992.11 crores during the period ended June 30, 2025
Sigachi Industries has reported total income of Rs. 132.18 crores during the period ended June 30, 2025
Laurus Labs has reported total income of Rs. 1,580 crores during the period ended June 30, 2025
Solara Active Pharma Sciences has reported total income of Rs. 320.13 crores during the period ended June 30, 2025
_256_384.jpg)
Cipla has reported total income of Rs. 7,216.03 crores during the period ended June 30, 2025
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
This is the second and final phase of the overall capacity addition of ?195 kL which was under construction at Unit IV Bidar facility
The use of Apisolex polymer excipient has been proven to increase the solubility of certain APIs by as much as 50,000-fold
Subscribe To Our Newsletter & Stay Updated
